Literature DB >> 16767488

Candida colonization of the vagina in elderly residents of a long-term-care hospital.

M Dan1, R Segal, V Marder, A Leibovitz.   

Abstract

The present study was conducted in order to determine the prevalence of vaginal colonization by Candida spp in elderly residents of a long-term-care hospital and to examine the determinants of vaginal candidiasis. Vaginal swabs for Gram stain and culture were obtained from 106 bedridden residents of a long-term-care hospital (study group; mean age, 83+/-7 years) and a control group of 50 similarly aged women admitted to an acute-care hospital for non-genital problems (mean age, 81+/-8 years). The characteristics of patients who tested positive for Candida spp were compared with those who tested negative. Candida spp were isolated from 34 (32%) patients in the study group and from four (8%) control patients (p=0.001). In the study group, Candida glabrata was by far the most common species isolated (51.2%). The warm and moist environment in the perineal area created by diaper use in incontinent individuals, together with decubitus ulcers and immobilization, which are common in elderly patients receiving long-term care, might be responsible for the high occurrence of vaginal colonization with Candida in these women.

Entities:  

Mesh:

Year:  2006        PMID: 16767488     DOI: 10.1007/s10096-006-0150-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Risk factors for Candida vulvovaginitis.

Authors:  B D Reed
Journal:  Obstet Gynecol Surv       Date:  1992-08       Impact factor: 2.347

2.  Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy.

Authors:  S L Hillier; R J Lau
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

Review 3.  Vaginitis.

Authors:  J D Sobel
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

4.  The relationship of bacterial vaginosis, Candida and Trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic.

Authors:  A Spinillo; A M Bernuzzi; C Cevini; R Gulminetti; S Luzi; A De Santolo
Journal:  Maturitas       Date:  1997-07       Impact factor: 4.342

5.  Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species.

Authors:  H Fricker-Hidalgo; S Orenga; B Lebeau; H Pelloux; M P Brenier-Pinchart; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women.

Authors:  Tiene G m Bauters; Marc A Dhont; Marleen I L Temmerman; Hans J Nelis
Journal:  Am J Obstet Gynecol       Date:  2002-09       Impact factor: 8.661

Review 7.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Torulopsis glabrata vaginitis.

Authors:  A Spinillo; E Capuzzo; T O Egbe; F Baltaro; S Nicola; G Piazzi
Journal:  Obstet Gynecol       Date:  1995-06       Impact factor: 7.661

9.  Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida.

Authors:  A M Geiger; B Foxman; J D Sobel
Journal:  Genitourin Med       Date:  1995-10
  9 in total
  8 in total

1.  Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.

Authors:  Scott E Gygax; John-Paul Vermitsky; Sean G Chadwick; Matthew J Self; Jessica A Zimmerman; Eli Mordechai; Martin E Adelson; Jason P Trama
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

2.  UPC2A is required for high-level azole antifungal resistance in Candida glabrata.

Authors:  Sarah G Whaley; Kelly E Caudle; John-Paul Vermitsky; Sean G Chadwick; Geoffrey Toner; Katherine S Barker; Scott E Gygax; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling.

Authors:  Ahmet Barış Guzel; Macit Ilkit; Refik Burgut; Ibrahim Ferhat Urunsak; Fatma Tuncay Ozgunen
Journal:  Mycopathologia       Date:  2011-02-04       Impact factor: 2.574

4.  Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection.

Authors:  John-Paul Vermitsky; Matthew J Self; Sean G Chadwick; Jason P Trama; Martin E Adelson; Eli Mordechai; Scott E Gygax
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

Review 5.  Mycoses in the elderly.

Authors:  H Hof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-13       Impact factor: 3.267

6.  Hosting infection: experimental models to assay Candida virulence.

Authors:  Donna M Maccallum
Journal:  Int J Microbiol       Date:  2011-12-22

Review 7.  Superficial Mycoses Associated with Diaper Dermatitis.

Authors:  Alexandro Bonifaz; Rubí Rojas; Andrés Tirado-Sánchez; Dinora Chávez-López; Carlos Mena; Luz Calderón; Ponce-Olivera Rosa María
Journal:  Mycopathologia       Date:  2016-05-19       Impact factor: 2.574

Review 8.  Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata.

Authors:  Ahmed Gamal; Sherman Chu; Thomas S McCormick; Katyna Borroto-Esoda; David Angulo; Mahmoud A Ghannoum
Journal:  Front Cell Infect Microbiol       Date:  2021-03-11       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.